Martín, M., González-Rivera, M., Morales, S., De La Haba-Rodriguez, J., González-Cortijo, L., Manso, L., . . . Prat, A. (2015). Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer.

Martín, Miguel, Milagros González-Rivera, Serafín Morales, Juan De La Haba-Rodriguez, Lucía González-Cortijo, Luis Manso, Joan Albanell, Luis de la Cruz Merino, and Aleix Prat. Prospective Study of the Impact of the Prosigna Assay On Adjuvant Clinical Decision-making in Unselected Patients With Estrogen Receptor-positive, HER2-negative, Node-negative Early-stage Breast Cancer. 2015.

Martín, Miguel, et al. Prospective Study of the Impact of the Prosigna Assay On Adjuvant Clinical Decision-making in Unselected Patients With Estrogen Receptor-positive, HER2-negative, Node-negative Early-stage Breast Cancer. 2015.